Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Recombinant IL-33 isoform with the G171S substitution had approximately 50% of activity of normal isoform in NF-κB-dependent reporter assay, and reduced bioactivity (∼65% of normal) to provoke eosinophilia when injected into mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP173510.RArcg_QRXXlpvSl6fBqMAbN6RQcDYbvF7sihpCYeeEWVs130_assertion description "[Recombinant IL-33 isoform with the G171S substitution had approximately 50% of activity of normal isoform in NF-κB-dependent reporter assay, and reduced bioactivity (∼65% of normal) to provoke eosinophilia when injected into mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP173510.RArcg_QRXXlpvSl6fBqMAbN6RQcDYbvF7sihpCYeeEWVs130_provenance.
• NP461561.RAHKCoEQPQKtvFsnAfmYIGE7pM3PyZ7-yquMAcFIzQyYc130_assertion description "[Recombinant IL-33 isoform with the G171S substitution had approximately 50% of activity of normal isoform in NF-κB-dependent reporter assay, and reduced bioactivity (∼65% of normal) to provoke eosinophilia when injected into mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP461561.RAHKCoEQPQKtvFsnAfmYIGE7pM3PyZ7-yquMAcFIzQyYc130_provenance.
• NP524035.RA5ZvI9wN-kYXpZ4ObPSpstA_KMrurNvQgXNigfz7QNFQ130_assertion description "[Recombinant IL-33 isoform with the G171S substitution had approximately 50% of activity of normal isoform in NF-κB-dependent reporter assay, and reduced bioactivity (∼65% of normal) to provoke eosinophilia when injected into mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP524035.RA5ZvI9wN-kYXpZ4ObPSpstA_KMrurNvQgXNigfz7QNFQ130_provenance.
• NP819836.RA7ag7H7xWNUD3lAqOh-pY-KFma5SYu5TSUESVXgXpKag130_assertion description "[Recombinant IL-33 isoform with the G171S substitution had approximately 50% of activity of normal isoform in NF-κB-dependent reporter assay, and reduced bioactivity (∼65% of normal) to provoke eosinophilia when injected into mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP819836.RA7ag7H7xWNUD3lAqOh-pY-KFma5SYu5TSUESVXgXpKag130_provenance.
• NP1056489.RAAs36nEcIHRg2hzk7cEjHrkcD0qXXs5MpFDyHA_7PD1Y130_assertion description "[Recombinant IL-33 isoform with the G171S substitution had approximately 50% of activity of normal isoform in NF-κB-dependent reporter assay, and reduced bioactivity (∼65% of normal) to provoke eosinophilia when injected into mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1056489.RAAs36nEcIHRg2hzk7cEjHrkcD0qXXs5MpFDyHA_7PD1Y130_provenance.
• NP1056492.RADACCWwsQccJIe5WirBCOhdnTLDMlr2KMN8I-SMdau9A130_assertion description "[Recombinant IL-33 isoform with the G171S substitution had approximately 50% of activity of normal isoform in NF-κB-dependent reporter assay, and reduced bioactivity (∼65% of normal) to provoke eosinophilia when injected into mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1056492.RADACCWwsQccJIe5WirBCOhdnTLDMlr2KMN8I-SMdau9A130_provenance.
• NP590740.RA8jOOe7YSO51YRBhtuBRRgmrp2ZX4UfEIgZwm56XcEbI130_assertion description "[Recombinant IL-33 isoform with the G171S substitution had approximately 50% of activity of normal isoform in NF-κB-dependent reporter assay, and reduced bioactivity (∼65% of normal) to provoke eosinophilia when injected into mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP590740.RA8jOOe7YSO51YRBhtuBRRgmrp2ZX4UfEIgZwm56XcEbI130_provenance.
• NP1056493.RA8IjZWF6Cnq1RM_LpPFftcDcRpjALRbH-XCWSw4NMh1w130_assertion description "[Recombinant IL-33 isoform with the G171S substitution had approximately 50% of activity of normal isoform in NF-κB-dependent reporter assay, and reduced bioactivity (∼65% of normal) to provoke eosinophilia when injected into mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1056493.RA8IjZWF6Cnq1RM_LpPFftcDcRpjALRbH-XCWSw4NMh1w130_provenance.
• NP589937.RAolYxJGsIOjtIFJj2MxySwyytI0aVUMyHNc4Q3uOEqyg130_assertion description "[Recombinant IL-33 isoform with the G171S substitution had approximately 50% of activity of normal isoform in NF-κB-dependent reporter assay, and reduced bioactivity (∼65% of normal) to provoke eosinophilia when injected into mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP589937.RAolYxJGsIOjtIFJj2MxySwyytI0aVUMyHNc4Q3uOEqyg130_provenance.
• NP590819.RAj3keSrdii6TadZ57QTR_hbtrxy1wjWiG0OelcjONPug130_assertion description "[Recombinant IL-33 isoform with the G171S substitution had approximately 50% of activity of normal isoform in NF-κB-dependent reporter assay, and reduced bioactivity (∼65% of normal) to provoke eosinophilia when injected into mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP590819.RAj3keSrdii6TadZ57QTR_hbtrxy1wjWiG0OelcjONPug130_provenance.